LBIO-115

N/A

Report date: 2026/05/13 09:11:41

Base Information

Drug NameLBIO-115

Drug Alias NameLBIO-115

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > snRNACell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionDystrophin gene transference

TargetsDystrophin

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLocanabio Inc

China Registration ClassN/A

Develop Information

Active CompaniesLocanabio Inc

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A